Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease.

Kavvoura FK, McQueen MB, Khoury MJ, Tanzi RE, Bertram L, Ioannidis JP.

Am J Epidemiol. 2008 Oct 15;168(8):855-65. doi: 10.1093/aje/kwn206. Epub 2008 Sep 8.

2.

Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk.

Tsilidis KK, Papatheodorou SI, Evangelou E, Ioannidis JP.

J Natl Cancer Inst. 2012 Dec 19;104(24):1867-78. doi: 10.1093/jnci/djs437. Epub 2012 Oct 22.

PMID:
23090067
3.

Evaluation of excess significance bias in animal studies of neurological diseases.

Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, Al-Shahi Salman R, Macleod MR, Ioannidis JP.

PLoS Biol. 2013 Jul;11(7):e1001609. doi: 10.1371/journal.pbio.1001609. Epub 2013 Jul 16.

4.

A multi-center study of ACE and the risk of late-onset Alzheimer's disease.

Belbin O, Brown K, Shi H, Medway C, Abraham R, Passmore P, Mann D, Smith AD, Holmes C, McGuinness B, Craig D, Warden D, Heun R, Kölsch H, Love S, Kalsheker N, Williams J, Owen MJ, Carrasquillo M, Younkin S, Morgan K, Kehoe PG.

J Alzheimers Dis. 2011;24(3):587-97. doi: 10.3233/JAD-2011-101914.

5.

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE.

Nat Genet. 2007 Jan;39(1):17-23.

PMID:
17192785
6.

Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations.

Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP.

Am J Epidemiol. 2006 Feb 15;163(4):300-9. Epub 2006 Jan 12.

PMID:
16410351
7.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
8.

An exploratory test for an excess of significant findings.

Ioannidis JP, Trikalinos TA.

Clin Trials. 2007;4(3):245-53.

PMID:
17715249
9.

GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis.

Wang M, Li Y, Lin L, Song G, Deng T.

Mol Neurobiol. 2016 Mar;53(2):1355-64. doi: 10.1007/s12035-015-9092-7. Epub 2015 Jan 30.

PMID:
25633095
10.
11.

Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.

Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A.

Cochrane Database Syst Rev. 2014 Oct 1;(10):MR000035. doi: 10.1002/14651858.MR000035.pub2.

PMID:
25271098
12.

Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis.

Rainero I, Bo M, Ferrero M, Valfrè W, Vaula G, Pinessi L.

Neurobiol Aging. 2004 Nov-Dec;25(10):1293-8.

PMID:
15465625
13.

Glutathione S-transferases variants as risk factors in Alzheimer's disease.

Wang T.

Neurol Sci. 2015 Oct;36(10):1785-92. doi: 10.1007/s10072-015-2245-7. Epub 2015 May 17.

PMID:
25981226
14.

Assessment of Alzheimer's disease case-control associations using family-based methods.

Schjeide BM, McQueen MB, Mullin K, DiVito J, Hogan MF, Parkinson M, Hooli B, Lange C, Blacker D, Tanzi RE, Bertram L.

Neurogenetics. 2009 Feb;10(1):19-25. doi: 10.1007/s10048-008-0151-3. Epub 2008 Oct 2.

15.

Lack of genetic associations between PPAR-γ gene rs1801282 polymorphism and Alzheimer's disease in general population: a meta-analysis.

Wu Y, Wu Q, Zhang H, Chen C, Chen G, Yang H, Qin D, Fu H.

Gene. 2015 Jun 1;563(2):120-4. doi: 10.1016/j.gene.2015.03.014. Epub 2015 Mar 11.

PMID:
25770052
16.

Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis.

Cheng H, Wang L, Shi T, Shang Y, Jiang L.

Int J Neurosci. 2015 May;125(5):328-35. doi: 10.3109/00207454.2014.941440. Epub 2014 Sep 16.

PMID:
25105907
17.

Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis.

Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, Licastro F, Colonna-Romano G, Lio D, Candore G, Caruso C.

Brain Res Rev. 2008 Nov;59(1):155-63. doi: 10.1016/j.brainresrev.2008.07.003. Epub 2008 Jul 21. Review.

PMID:
18675847
18.

Association between polymorphism of COMT gene (Val158Met) with Alzheimer's disease: An updated analysis.

Yan W, Zhao C, Sun L, Tang B.

J Neurol Sci. 2016 Feb 15;361:250-5. doi: 10.1016/j.jns.2016.01.014. Epub 2016 Jan 7.

PMID:
26810551
19.

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.

Jin C, Li W, Yuan J, Xu W, Cheng Z.

Neurosci Lett. 2012 Oct 3;527(1):46-9. doi: 10.1016/j.neulet.2012.08.032. Epub 2012 Aug 27.

PMID:
22960360
20.

Effect of formal statistical significance on the credibility of observational associations.

Ioannidis JP.

Am J Epidemiol. 2008 Aug 15;168(4):374-83; discussion 384-90. doi: 10.1093/aje/kwn156. Epub 2008 Jul 8. Review.

PMID:
18611956

Supplemental Content

Support Center